Drawing for PLX PHARMA

USPTO serial 86393682

PLX PHARMA

Reviewed by CopyMark Law Group

Reg. 4879464Status 710
Filing date
Status date
Registration date
Jan 5, 2016
Examiner
TENG, SIMON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PLX PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mary L. Grieco

Mary L. Grieco Olshan Frome Wolosky LLP1325 Avenue of the AmericasNew York, NY 10019UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Research and development services for pharmaceutical preparations and substances, namely, phospholipid and non-steroidal anti-inflammatory drug containing preparations; providing medical and scientific research information in the fields of pharmaceuticalsSECTION 8 - CANCELLEDJan 1, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 15, 2022C8..CANCELLED SEC. 8 (6-YR)—
Jan 5, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 28, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 28, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 12, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 12, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 6, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 5, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 20, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 11, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Sep 11, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 11, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 11, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 4, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 4, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 28, 2015ALIEASSIGNED TO LIE—
Aug 14, 2015NREVNOTICE OF REVIVAL - E-MAILED—
Aug 14, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 14, 2015PETGPETITION TO REVIVE-GRANTED—
Aug 14, 2015PROATEAS PETITION TO REVIVE RECEIVED—
Jul 9, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 9, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 11, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 11, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2014DOCKASSIGNED TO EXAMINER—
Sep 19, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 16, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance